ELISA confirmed a borderline significant rise in beta‐2‐microglobulin within two years of diagnosis in EPIC.
← all excerpts
A proteomics approach to identify predictive blood biomarkers for pleural mesothelioma in prospective cohorts.
3
—
—
The sentences
Subsequent ELISA validation in the discovery cohort confirmed reproducible trends for B2M, C4, TF, and DCD, although only B2M demonstrated a borderline significance and association in cases sampled within two years of diagnosis.
TF, C4, and DCD trended similarly to discovery data but did not reach statistical significance.